Back
 JBM  Vol.6 No.6 , June 2018
Pattern of Cervical Cytology and High Risk Human Papillomavirus Strains in Non HIV Positive Women Presenting for Cervical Cancer Screening in Port Harcourt, Nigeria
Abstract: Background: The high risk human papilloma virus (hrHPV) is largely associated with cervical cancer with identifiable dysplastic changes on cytology. The use of cervical cancer screening strategies has largely improved the general outcome of cervical malignancies globally. Objective: To compare cervical cytological features against human papilloma virus genotypes in non HIV positive patients presenting for cervical cancer screening in UPTH. Method: A cross sectional prospective study of 82 non HIV positive women who presented for cervical cancer screening at the University of Port Harcourt Teaching hospital. A prestructured questionnaire was used to obtain socio demographic information. Cytobrush extracts of cervical samples were subjected to cytology and human papilloma virus DNA genotyping using real-time polymerase chain reaction. The information obtained was analyzed using SSPP version 20 and results presented as frequency tables, percentages and tested for significance using student t-test and chi square with p value < 0.05 at 95% confidence interval. Results: The mean age of the women was 36.61 ± 7.75 with an age range of 22 - 58 years. The prevalence of HrHPV was 4.88%. Twenty-two of the respondent have abnormal cytological pattern. While the 4 cases of HrHPV positivity were of normal cytological pattern and occurred in respondents that were in their reproductive age, the 22 that showed abnormal cervical cytology were mainly of low grade squamous intraepithelial lesion (LGSIL). There was no case of high grade squamous cell intraepithelial lesion (HGSIL). Conclusion: HrHPV prevalence rate of 4.88% occurring in low socioeconomic class patients. All the cervical abnormalies were of LGSIL, hence the risk of transformation into cervical cancer is equally low. There may be no correlation between hrHPV and cervical cytology in low risk patients.
Cite this paper: Nyengidiki, T. and Oranu, E. (2018) Pattern of Cervical Cytology and High Risk Human Papillomavirus Strains in Non HIV Positive Women Presenting for Cervical Cancer Screening in Port Harcourt, Nigeria. Journal of Biosciences and Medicines, 6, 68-76. doi: 10.4236/jbm.2018.66005.
References

[1]   Ferlay, J., Soerjomataran, I., Dikshart, R. et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBACAN. International Journal of Cancer, 136, E359-E386.
https://doi.org/10.1002/ijc.29210

[2]   IARC GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. IARC.
http://globocan.fr

[3]   Okonofua, F. (2007) Human Papilloma Virus and Prevention of Cervical Cancer in Africa. African Journal of Reproductive Health, 117-122.

[4]   Kamager, F., Dores, G.M. and Anderson, W.F. (2008) Pattern of Cervical Cancer Incidence Mortality and Prevalence across Five Different Continent Defining Geographical reGions of the World. Journal of Clinical Oncology, 24, 2137-2150.
https://doi.org/10.1200/JCO.2005.05.2308

[5]   Larra, E., Dayen, E. and Hakama, M. (1987) Trend in Cervical Mortality in Nordic Countries Association with Organized Screening Programmes. Lancet, 30, 1247-1249.

[6]   Linday, A.T., Freddie, B., Rebbeca, I.S., Jacques, F. and Ahmedin, J. (2015) Global Cancer. Journal of Clinical Practice, 56, 87-108.

[7]   Anttla, A., Aasmaa, A., Fender, M., Patrick, J., Rebil, M., Nicula, F., et al. (2009) Cervical Cancer Screening Policies and Coverage in Europe. European Journal of Cancer, 45, 2649-2658.
https://doi.org/10.1016/j.ejca.2009.07.020

[8]   Bassey, G., Nyengidiki, T.K. and Onwubuariri, M. (2015) Profile and Retrospective Analysis of the Use of Preventive Strategies in Patients with Cervical Cancer in South-South Nigeria. Nigerian Medical Journal, 56, 109-112.
https://doi.org/10.4103/0300-1652.150693

[9]   Human Papillomavirus: Genital HPV Infection. Fact Sheet. Centre for Disease Control and Prevention 2014.

[10]   Boach, F.X., Lortinez, A., Munoz, N., Mejer, C.J. and Shark, K.V. (2002) The Casual Relationship between HPV and Cervical Cancer. Journal of Clinical Pathology, 4, 1244-1265.

[11]   Winer, R.L., Feng, Q., Hughes, J.P., Orely, S., Kivt, N.B. and Koutsky, L.A. (2008) Risk Factors of Female Human Papilloma Virus Acquisition Associated with First Male Sex Partners. The Journal of Infectious Diseases, 197, 279-282.
https://doi.org/10.1086/524875

[12]   Magnet, S. (2010) HPV Immune Response to Infection and Vaccination. Infectious Agent and Cancer, 19-25.

[13]   Pooja, P., Mala, Y.M., Tripathic, R., Das, B.C. and Bhambram, S. (2014) Human Papillomavirus (HPV) Infection and Abnormal Cytopathology among HIV Positive Women in India. Journal of AIDS and HIV Research, 6, 1-6.
https://doi.org/10.5897/JAHR10.033

[14]   HPV Prevalence and Type-Distribution in Crervical Cancer and Premalignant Lesion of Cervix: A Population Based Study from Northern Ireland. Journal of Medical Virology, 88, 1262-1270.
https://doi.org/10.1002/jmv.24447

[15]   Bud Ellien, M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-7.
https://doi.org/10.1128/CMR.16.1.1-17.2003

[16]   National Cancer Institute (2015) Hpv and Cancer.
http://www.cancer.gov

[17]   Nyengidiki, T.K. and Athanasius, P.B. (2016) High Risk Human Papiloma Virus Genotyping and Cervical Cytology as Screening Test for Cervical Cancer in Human Immunodeficiency Virus Positive Women in Nigeria. Journal of Cancer and Tumor International, 3, 1-7.
https://doi.org/10.9734/JCTI/2016/25209

[18]   Veldnujien, N.J., Srigder, P.J., Reiss, P., Majer, C.J. and Van de Wjgert, J.A. (2010) Factors Affecting Transmission of Mucosal Human Papilloma Virus. The Lancet Infectious Diseases, 10, 862-874.
https://doi.org/10.1016/S1473-3099(10)70190-0

[19]   Nyengidiki, T.K., Durugbo, I.K. and Oranu, E.O. (2016) Human Papillomavirus Awareness and Uptake of HPV Vaccination among Human Immunodeficiency Virus Positive Women in Nigeria. International Journal of Tropical Disease & Health, 15, 1-7.
https://doi.org/10.9734/IJTDH/2016/25241

[20]   Khan, M.J., Pstidge, E.E., Wang, S.S. and Shiffman, M. (2005) Socioeconomic Status and the Risk of Cervical Intraepithelial Neoplasm Grade 3 among Oncogenic Human Papillomavirus DNA Positive Women with Equivocal Abnormal Cytology. Cancer, 1004, 61-70.
https://doi.org/10.1002/cncr.21129

[21]   Katik, H.A., Kinney, W.K., Fetterman, B., Lory, T., Poitrar, N.E., Cheung, L., et al. (2011) Cervical Cancer Risk for Women Undergoing Concurrent Testing for Human Papillomavirus and Cervical Cytology: A Population Based Study in Clinical Practice. The Lancet Oncology, 12, 663-673.
https://doi.org/10.1016/S1470-2045(11)70145-0

[22]   Faruk, M.K. and Murat, M.N. (2014) Cervical Premalignant Lesion and Their Management. Journal of the Turkish-German Gynecological Association, 15, 109-121.
https://doi.org/10.5152/jtgga.2014.29795

[23]   Stancy, B., Zaibo, L., Marshall, A. and Chegquam, Z. (2014) Low Grade Squamous Cell Intraepithelial Lesion Cannot Exclude High Grade Squmous Cell Intraepithelial Lesion. American Journal of Clinical Pathology, 141, 239-246.
https://doi.org/10.1309/AJCPM9X5RCZYEQJQ

 
 
Top